Bassem Attalla

Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1–34)

Jacquelin Jolette, Bassem Attalla, Aurore Varela et al. · Regulatory Toxicology and Pharmacology · 2017 · 96 citations · Full text

Medicine, Endocrinology, Pharmacology +15

REVERSIBLE AND SPECIES-SPECIFIC DEPIGMENTATION EFFECTS OF AZD3293, A BACE INHIBITOR FOR THE TREATMENT OF ALZHEIMER’S DISEASE, ARE RELATED TO BACE2 INHIBITION AND CONFINED TO EPIDERMIS AND HAIR

Gvido Cebers, T. Lejeune, Bassem Attalla et al. · The Journal of Prevention of Alzheimer s Disease · 2016 · 20 citations · Full text

Life Sciences, Neuroscience, Pharmacology +12

A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin

Martin Billger, Jason Kirk, Jane Chang et al. · Regulatory Toxicology and Pharmacology · 2019 · 13 citations · Full text

Medicine, Oncology, Pharmacology +13